|
England and Wales
|
001-35573
|
98-1467236
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
263 Tresser Boulevard, Suite 1100
|
Laporte Road, Stallingborough
|
|
|
Stamford, Connecticut 06901
|
Grimsby, North East Lincolnshire, DN40 2PR, UK
|
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
Trading Symbol(s)
|
Name of exchange on which registered
|
| Ordinary shares, par value $0.01 per share | TROX |
NYSE |
| Item 2.02. |
Results of Operations and Financial Condition.
|
|
Item 9.01.
|
Financial Statements and Exhibits.
|
|
Exhibit
No.
|
Description
|
|
|
Earnings Release, dated July 30, 2025.
|
||
|
104
|
Inline XBRL for the cover page of this Current Report on Form 8-K.
|
|
TRONOX HOLDINGS PLC
|
||
|
Date: July 31, 2025
|
By:
|
/s/ Jeffrey N. Neuman
|
|
Name:
|
Jeffrey N. Neuman
|
|
|
Title:
|
Senior Vice President, General Counsel and Secretary
|

| ● |
Revenue of $731 million, a 1% decrease compared to the prior quarter and an 11% decrease compared to the prior year
|
| ● |
Loss from operations of $35 million; Net loss of $85
million including $39 million of restructuring and other charges, net of taxes, primarily costs associated with the idling of the Company's Botlek pigment
plant as announced in March; adjusted net loss was $45 million (non-GAAP)
|
| ● |
GAAP diluted loss per share was $0.53; Adjusted diluted loss per share was $0.28 (non-GAAP)
|
| ● |
Adjusted EBITDA of $93 million; Adjusted EBITDA margin of 12.7% (non-GAAP)
|
| ● |
Capital expenditures of $83 million in the quarter
|
| ● |
Expect 2025 Revenue of $3.0-$3.1 billion, Adjusted EBITDA of $410-$460 million, and free cash flow to be a use of $100-$170 million
|
| ● |
In response to the extended market downturn, the Company is adjusting its capital allocation priorities by further reducing capital expenditures (now expected to be less than $330 million) and
reducing the dividend by 60% to provide near-term balance sheet flexibility
|
|
($M unless otherwise noted)
|
Q2 2025
|
Q2 2024
|
Y-o-Y % ∆
|
|
Q1 2025
|
Q-o-Q % ∆
|
|
||||||||||||||
|
Revenue
|
$
|
731
|
$
|
820
|
(11
|
)%
|
$
|
738
|
(1
|
)%
|
|||||||||||
|
TiO2
|
$
|
587
|
$
|
653
|
(10
|
)%
|
$
|
584
|
1
|
%
|
|||||||||||
|
Zircon
|
$
|
68
|
$
|
85
|
(20
|
)%
|
$
|
69
|
(1
|
)%
|
|||||||||||
|
Other products
|
$
|
76
|
$
|
82
|
(7
|
)%
|
$
|
85
|
(11
|
)%
|
|||||||||||
|
(Loss) Income from operations
|
$
|
(35
|
)
|
$
|
76
|
n/m
|
|
$
|
(61
|
)
|
n/m
|
|
|||||||||
|
Net (Loss) Income attributable to Tronox
|
$
|
(84
|
)
|
$
|
16
|
n/m
|
|
$
|
(111
|
)
|
n/m
|
|
|||||||||
|
GAAP diluted (loss) earnings per share
|
$
|
(0.53
|
)
|
$
|
0.10
|
n/m
|
|
$
|
(0.70
|
)
|
n/m
|
|
|||||||||
|
Adjusted diluted (loss) earnings per share
|
$
|
(0.28
|
)
|
$
|
0.07
|
n/m
|
|
$
|
(0.15
|
)
|
n/m
|
|
|||||||||
|
Adjusted EBITDA
|
$
|
93
|
$
|
161
|
(42
|
)%
|
$
|
112
|
(17
|
)%
|
|||||||||||
|
Adjusted EBITDA Margin %
|
12.7
|
%
|
19.6
|
%
|
(690) bps
|
15.2
|
%
|
(250) bps
|
|||||||||||||
|
Free cash flow
|
$
|
(55
|
)
|
$
|
84
|
n/m
|
|
$
|
(142
|
)
|
n/m
|
|
|||||||||
|
Y-o-Y % ∆
|
Q-o-Q % ∆
|
||||||
|
Volume
|
Price / Mix
|
FX
|
Volume
|
Price / Mix
|
FX
|
||
|
TiO2
|
(11)%
|
0%
|
1%
|
(2)%
|
1%
|
2%
|
|
|
Zircon
|
(10)%
|
(10)%
|
—
|
1%
|
(2)%
|
—
|
|
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net sales
|
$
|
731
|
$
|
820
|
$
|
1,469
|
$
|
1,594
|
||||||||
|
Cost of goods sold
|
652
|
670
|
1,291
|
1,324
|
||||||||||||
|
Gross profit
|
79
|
150
|
178
|
270
|
||||||||||||
|
Restructuring and other charges
|
42
|
—
|
128
|
—
|
||||||||||||
|
Selling, general and administrative expenses
|
72
|
74
|
146
|
153
|
||||||||||||
|
(Loss) Income from operations
|
(35
|
)
|
76
|
(96
|
)
|
117
|
||||||||||
|
Interest expense
|
(45
|
)
|
(42
|
)
|
(87
|
)
|
(84
|
)
|
||||||||
|
Interest income
|
1
|
2
|
3
|
6
|
||||||||||||
|
Other (expense) income, net
|
(2
|
)
|
19
|
(7
|
)
|
18
|
||||||||||
|
(Loss) Income before income taxes
|
(81
|
)
|
55
|
(187
|
)
|
57
|
||||||||||
|
Income tax provision
|
(4
|
)
|
(45
|
)
|
(9
|
)
|
(56
|
)
|
||||||||
|
Net (loss) income
|
(85
|
)
|
10
|
(196
|
)
|
1
|
||||||||||
|
Net loss attributable to noncontrolling interest
|
(1
|
)
|
(6
|
)
|
(1
|
)
|
(6
|
)
|
||||||||
|
Net (loss) income attributable to Tronox Holdings plc
|
$
|
(84
|
)
|
$
|
16
|
$
|
(195
|
)
|
$
|
7
|
||||||
|
(Loss) Income per share:
|
||||||||||||||||
|
Basic
|
$
|
(0.53
|
)
|
$
|
0.10
|
$
|
(1.23
|
)
|
$
|
0.04
|
||||||
|
Diluted
|
$
|
(0.53
|
)
|
$
|
0.10
|
$
|
(1.23
|
)
|
$
|
0.04
|
||||||
|
Weighted average shares outstanding, basic (in thousands)
|
158,561
|
158,117
|
158,358
|
157,730
|
||||||||||||
|
Weighted average shares outstanding, diluted (in thousands)
|
158,561
|
159,288
|
158,358
|
158,902
|
||||||||||||
|
Other Operating Data:
|
||||||||||||||||
|
Capital expenditures
|
83
|
76
|
193
|
152
|
||||||||||||
|
Depreciation, depletion and amortization expense
|
74
|
72
|
145
|
144
|
||||||||||||
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net (loss) income attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
(84
|
)
|
$
|
16
|
$
|
(195
|
)
|
$
|
7
|
||||||
|
Restructuring and other charges (a)
|
38
|
—
|
124
|
—
|
||||||||||||
|
Tax valuation allowance (b)
|
—
|
16
|
—
|
16
|
||||||||||||
|
Sale of royalty interest (c)
|
—
|
(21
|
)
|
—
|
(21
|
)
|
||||||||||
|
Other (d)
|
1
|
1
|
2
|
2
|
||||||||||||
|
Adjusted net (loss) income attributable to Tronox Holdings plc (non-U.S. GAAP) (1)
|
$
|
(45
|
)
|
$
|
12
|
$
|
(69
|
)
|
$
|
4
|
||||||
|
Diluted net (loss) income per share (U.S. GAAP)
|
$
|
(0.53
|
)
|
$
|
0.10
|
$
|
(1.23
|
)
|
$
|
0.04
|
||||||
|
Restructuring and other charges, per share
|
0.24
|
—
|
0.78
|
—
|
||||||||||||
|
Tax valuation allowance, per share
|
—
|
0.10
|
—
|
0.10
|
||||||||||||
|
Sale of royalty interest, per share
|
—
|
(0.14
|
)
|
—
|
(0.13
|
)
|
||||||||||
|
Other, per share
|
0.01
|
0.01
|
0.01
|
0.01
|
||||||||||||
|
Diluted adjusted net (loss) income per share attributable to Tronox Holdings plc (non-U.S. GAAP) (2)
|
$
|
(0.28
|
)
|
$
|
0.07
|
$
|
(0.44
|
)
|
$
|
0.02
|
||||||
|
Weighted average shares outstanding, diluted (in thousands)
|
158,561
|
159,288
|
158,358
|
158,902
|
||||||||||||
|
June 30, 2025
|
December 31, 2024
|
|||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$
|
132
|
$
|
151
|
||||
|
Restricted cash
|
1
|
1
|
||||||
|
Accounts receivable (net of allowance for credit losses of $1 and $1 as of June 30, 2025 and December 31, 2024, respectively)
|
294
|
266
|
||||||
|
Inventories, net
|
1,685
|
1,551
|
||||||
|
Prepaid and other assets
|
124
|
184
|
||||||
|
Income taxes receivable
|
2
|
2
|
||||||
|
Total current assets
|
2,238
|
2,155
|
||||||
|
Noncurrent Assets
|
||||||||
|
Property, plant and equipment, net
|
1,997
|
1,927
|
||||||
|
Mineral leaseholds, net
|
613
|
616
|
||||||
|
Intangible assets, net
|
227
|
244
|
||||||
|
Lease right of use assets, net
|
145
|
140
|
||||||
|
Deferred tax assets
|
833
|
830
|
||||||
|
Other long-term assets
|
133
|
126
|
||||||
|
Total assets
|
$
|
6,186
|
$
|
6,038
|
||||
|
LIABILITIES AND EQUITY
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable
|
$
|
500
|
$
|
499
|
||||
|
Accrued liabilities
|
239
|
247
|
||||||
|
Short-term lease liabilities
|
25
|
24
|
||||||
|
Short-term debt
|
266
|
65
|
||||||
|
Long-term debt due within one year
|
38
|
35
|
||||||
|
Income taxes payable
|
—
|
4
|
||||||
|
Total current liabilities
|
1068
|
874
|
||||||
|
Noncurrent Liabilities
|
||||||||
|
Long-term debt, net
|
2,749
|
2,759
|
||||||
|
Pension and postretirement healthcare benefits
|
88
|
85
|
||||||
|
Asset retirement obligations
|
204
|
172
|
||||||
|
Environmental liabilities
|
46
|
40
|
||||||
|
Long-term lease liabilities
|
114
|
107
|
||||||
|
Deferred tax liabilities
|
191
|
174
|
||||||
|
Other long-term liabilities
|
47
|
36
|
||||||
|
Total liabilities
|
4,507
|
4,247
|
||||||
|
Commitments and Contingencies
|
||||||||
|
Shareholders’ Equity
|
||||||||
|
Tronox Holdings plc ordinary shares, par value $0.01 — 158,524,635 shares issued and outstanding at June 30, 2025 and 157,938,056 shares issued and outstanding at
December 31, 2024
|
2
|
2
|
||||||
|
Capital in excess of par value
|
2,092
|
2,084
|
||||||
|
Retained earnings
|
321
|
555
|
||||||
|
Accumulated other comprehensive loss
|
(769
|
)
|
(880
|
)
|
||||
|
Total Tronox Holdings plc shareholders’ equity
|
1,646
|
1,761
|
||||||
|
Noncontrolling interest
|
33
|
30
|
||||||
|
Total equity
|
1,679
|
1,791
|
||||||
|
Total liabilities and equity
|
$
|
6,186
|
$
|
6,038
|
||||
|
Six Months Ended June 30,
|
||||||||
|
2025
|
2024
|
|||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net (loss) income
|
$
|
(196
|
)
|
$
|
1
|
|||
|
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
|
||||||||
|
Depreciation, depletion and amortization
|
145
|
144
|
||||||
|
Deferred income taxes
|
7
|
46
|
||||||
|
Share-based compensation expense
|
9
|
10
|
||||||
|
Amortization of deferred debt issuance costs and discount on debt
|
5
|
5
|
||||||
|
Restructuring and other charges
|
128
|
-
|
||||||
|
Other non-cash items affecting net income (loss)
|
29
|
13
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Increase in accounts receivable, net of allowance for credit losses
|
(19
|
)
|
(97
|
)
|
||||
|
(Increase) decrease in inventories, net
|
(76
|
)
|
8
|
|||||
|
Decrease in prepaid and other assets
|
29
|
10
|
||||||
|
Restructuring payments
|
(27
|
)
|
-
|
|||||
|
(Decrease) increase in accounts payable and accrued liabilities
|
(23
|
)
|
13
|
|||||
|
Net changes in income tax payables and receivables
|
(5
|
)
|
(2
|
)
|
||||
|
Changes in other non-current assets and liabilities
|
(10
|
)
|
(20
|
)
|
||||
|
Cash (used in) provided by operating activities
|
(4
|
)
|
131
|
|||||
|
Cash Flows from Investing Activities:
|
||||||||
|
Capital expenditures
|
(193
|
)
|
(152
|
)
|
||||
|
Loans
|
15
|
-
|
||||||
|
Proceeds from sale of assets
|
2
|
16
|
||||||
|
Cash used in investing activities
|
(176
|
)
|
(136
|
)
|
||||
|
Cash Flows from Financing Activities:
|
||||||||
|
Repayments of short-term debt
|
(11
|
)
|
(11
|
)
|
||||
|
Repayments of long-term debt
|
(14
|
)
|
(9
|
)
|
||||
|
Proceeds from short-term debt
|
203
|
-
|
||||||
|
Debt issuance costs
|
(1
|
)
|
(2
|
)
|
||||
|
Dividends paid
|
(20
|
)
|
(41
|
)
|
||||
|
Restricted stock and performance-based shares settled in cash for withholding taxes
|
(1
|
)
|
-
|
|||||
|
Cash provided by (used in) financing activities
|
156
|
(63
|
)
|
|||||
|
Effects of exchange rate changes on cash and cash equivalents and restricted cash
|
5
|
(4
|
)
|
|||||
|
Net decrease in cash and cash equivalents and restricted cash
|
(19
|
)
|
(72
|
)
|
||||
|
Cash and cash equivalents and restricted cash at beginning of period
|
152
|
273
|
||||||
|
Cash and cash equivalents and restricted cash at end of period
|
$
|
133
|
$
|
201
|
||||
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net (loss) income (U.S. GAAP)
|
$
|
(85
|
)
|
$
|
10
|
(196
|
)
|
1
|
||||||||
|
Interest expense
|
45
|
42
|
87
|
84
|
||||||||||||
|
Interest income
|
(1
|
)
|
(2
|
)
|
(3
|
)
|
(6
|
)
|
||||||||
|
Income tax provision
|
4
|
45
|
9
|
56
|
||||||||||||
|
Depreciation, depletion and amortization expense
|
74
|
72
|
145
|
144
|
||||||||||||
|
EBITDA (non-U.S. GAAP)
|
37
|
167
|
42
|
279
|
||||||||||||
|
Share-based compensation (a)
|
4
|
4
|
9
|
10
|
||||||||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (b)
|
7
|
7
|
14
|
14
|
||||||||||||
|
Accounts receivable securitization program (c)
|
3
|
4
|
7
|
7
|
||||||||||||
|
Foreign currency remeasurement (d)
|
(2
|
)
|
4
|
(1
|
)
|
2
|
||||||||||
|
Sale of royalty interest (e)
|
—
|
(28
|
)
|
—
|
(28
|
)
|
||||||||||
|
Restructuring and other charges (f)
|
42
|
—
|
128
|
—
|
||||||||||||
|
Other items (g)
|
2
|
3
|
6
|
8
|
||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
93
|
$
|
161
|
$
|
205
|
$
|
292
|
||||||||
|
Three Months Ended June 30,
|
||||||||
|
2025
|
2024
|
|||||||
|
Net sales
|
$
|
731
|
$
|
820
|
||||
|
Net (loss) income (U.S. GAAP)
|
$
|
(85
|
)
|
$
|
10
|
|||
|
Net (loss) income (U.S. GAAP) as a % of Net sales
|
(11.6
|
)%
|
1.2
|
%
|
||||
|
Adjusted EBITDA (non-U.S. GAAP) (see above) as a % of Net sales
|
12.7
|
%
|
19.6
|
%
|
||||
|
June 30, 2025
|
December 31, 2024
|
|||||||
|
Long-term debt, net
|
$
|
2,749
|
$
|
2,759
|
||||
|
Short-term debt
|
266
|
65
|
||||||
|
Long-term debt due within one year
|
38
|
35
|
||||||
|
(Less) Cash and cash equivalents
|
(132
|
)
|
(151
|
)
|
||||
|
Net debt
|
$
|
2,921
|
$
|
2,708
|
||||
|
Trailing-twelve month Adjusted EBITDA (non-U.S. GAAP)
|
$
|
477
|
$
|
564
|
||||
|
Net debt to trailing-twelve month Adjusted EBITDA (non-U.S. GAAP) (see above)
|
6.1
|
x
|
4.8
|
x
|
||||
|
Six Months Ended
June 30, 2025
|
Three Months Ended
March 31, 2025
|
Three Months Ended
June 30, 2025
|
||||||||||
|
Cash used in operating activities
|
$
|
(4
|
)
|
$
|
(32
|
)
|
$
|
28
|
||||
|
Capital expenditures
|
(193
|
)
|
(110
|
)
|
(83
|
)
|
||||||
|
Free cash flow (non-U.S. GAAP)
|
$
|
(197
|
)
|
$
|
(142
|
)
|
$
|
(55
|
)
|
|||
|
|
Three Months Ended
|
Trailing Twelve Month
Adjusted EBITDA
|
||||||||||||||||||
|
|
September 30, 2024
|
December 31, 2024
|
March 31, 2025
|
June 30, 2025
|
||||||||||||||||
|
Net loss (U.S. GAAP)
|
$
|
(25
|
)
|
$
|
(30
|
)
|
$
|
(111
|
)
|
$
|
(85
|
)
|
$
|
(251
|
)
|
|||||
|
Interest expense
|
42
|
41
|
42
|
45
|
170
|
|||||||||||||||
|
Interest income
|
(3
|
)
|
(1
|
)
|
(2
|
)
|
(1
|
)
|
(7
|
)
|
||||||||||
|
Income tax provision
|
26
|
45
|
5
|
4
|
80
|
|||||||||||||||
|
Depreciation, depletion and amortization expense
|
70
|
71
|
71
|
74
|
286
|
|||||||||||||||
|
EBITDA (non-U.S. GAAP)
|
110
|
126
|
5
|
37
|
278
|
|||||||||||||||
|
Share-based compensation (a)
|
7
|
4
|
5
|
4
|
20
|
|||||||||||||||
|
Foreign currency remeasurement (b)
|
8
|
(11
|
)
|
1
|
(2
|
)
|
(4
|
)
|
||||||||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (c)
|
8
|
1
|
7
|
7
|
23
|
|||||||||||||||
|
Accounts receivable securitization program (d)
|
4
|
4
|
4
|
3
|
15
|
|||||||||||||||
|
Restructuring and other charges (e)
|
—
|
—
|
86
|
42
|
128
|
|||||||||||||||
|
Loss on extinguishment of debt (f)
|
3
|
—
|
—
|
—
|
3
|
|||||||||||||||
|
Other items (g)
|
3
|
5
|
4
|
2
|
14
|
|||||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
143
|
$
|
129
|
$
|
112
|
$
|
93
|
$
|
477
|
||||||||||